We have reported previously that antisense c-jun overcomes a block of Friend erythroleukemia cells to dierentiation suggesting that the factor c-Jun may be an important negative regulator of erythroid dierentiation. The recently described erythroid transcription factor NF-E2 plays an important role in the regulation of the transcription of globin genes and recognizes a sequence containing an AP-1 site. NF-E2 is a complex of two bZip proteins, p45 and p18/Maf. In order to determine whether c-Jun can interact with NF-E2/AP-1 sites to regulate transcriptional activation from them, we have compared the activity of AP-1 and NF-E2 in transient transcriptional assays, in erythroid and nonerythroid cells in the presence of c-jun sense and antisense expression vectors. In non-erythroid cells, cJun activates and NF-E2p18 inhibits both AP-1 and NF-E2 activities, suggesting that NF-E2/AP-1 sites function as AP-1 binding sites in these cells. In contrast, NFE2p18 is a positive regulator of NF-E2 activity in erythroid cells. c-Jun alone is also a positive regulator of NF-E2 activity in erythroid cells but in association with NF-E2p18 inhibits this activity. Moreover antisense c-jun increases endogenous NF-E2 activity in erythroid cells. These results suggest that c-Jun could act as a repressor of NF-E2 transcriptional activity by forming inactive cJun/NF-E2p18 heterocomplexes which interfer with the transcription of globin genes in Friend erythroleukemia cells.
Keywords: c-Jun; NF-E2; transactivation; globin regulation; erythroleukemia Friend murine erythroleukemia (F-MEL) cells provide a useful system for studying the mechanisms which control erythroid dierentiation and globin gene expression. When exposed to DMSO or other inducers, F-MEL cells undergo phenotypic changes that resemble the ®nal stages of normal erythropoiesis (Friend et al., 1971; Chen et al., 1982) . The most striking feature is the increased synthesis of globin chains which results primarily from the activation of globin gene transcription (Charnay et al., 1984; Profous-Juchelka et al., 1983) . Expression of globin genes is dependent on far-upstream locus control regions (LCR) (Orkin, 1995) . The overall enhancer activity of the b-globin complex LCR requires the integrity of a short sequence in the HS-2 site, containing tandem binding sites for two transcription factors, the ubiquitous AP-1 complex and the erythroid NF-E2 complex (Mignotte et al., 1989a, b; Ney et al., 1990a and b; Talbot et al., 1991) . The importance of the NF-E2/AP-1 sites in globin gene expression has been inferred from mutagenesis experiments. Mutation of these sites within HS2 leads to a marked decrease in its enhancer activity on b-globin gene expression in tranfected erythroid cells and in transgenic mice (Caterina et al., 1991; Liu et al., 1992; Ney et al., 1990a, b; Talbot et al., 1991) . A direct evidence that the NF-E2 complex is critical for globin expression is provided by the existence of a F-MEL cell line in which retroviral integration results in inactivation of the NF-E2 transcriptional factor (Lu et al., 1994) . This line is associated with drastic reduction of globin RNA expression which can be restored by re-introducing NF-E2.
The NF-E2 complex, which was ®rst isolated from F-MEL cells, is a heterodimer of two bZip proteins of 45 and 18 kDa (Andrews et al., 1993a, b) . While NFE2p18 is widely expressed in many dierent cell types, NF-E2p45 expression is restricted to cells of the erythroid, megakaryocyte and mast cell lineage. Since NF-E2p45 homodimers cannot bind to NF-E2 motifs, NF-E2p45 binds as an obligate heterodimer with NFE2p18 (Andrews et al., 1993b) , to form the NF-E2 complex which has been described as the transcriptional activator of NF-E2 enhancer elements (Igarashi et al., 1994) . NF-E2p18 protein is encoded by a gene of the small Maf gene family lacking a putative transactivator domain (Andrews et al., 1993b; Fujiwara et al., 1993; Igarashi et al., 1995) . Homodimers of small Maf proteins suppress transcription from NF-E2/AP-1 sites in non-erythroid cells (Igarashi et al., 1994) . Maf proteins could also heterodimerize with bZip proteins from the Fos/Jun family (Kataoka et al., , 1995 Kerpola and Curran, 1994) . The Jun/Maf heterodimers have binding speci®cities distinct from those of the Jun/Jun and Maf/Maf homodimers but their transcriptional activity has not yet been reported. It is apparent that multiple forms of homo-and heterodimeric complexes of these bZip proteins can mediate a wide variety of transcriptional regulation.
We have recently reported that the proto-oncogene c-Jun may be a negative regulator of F-MEL erythroid dierentiation (Francastel et al., 1994) . Overexpression of c-jun inhibits F-MEL erythroid dierentiation whereas inhibition of c-jun by antisense transcripts in a dierentiation-resistant F-MEL cell line restores the sensitivity of these cells to DMSO-induced differentiation. Because c-Jun, as a homodimer or as a heterodimer together with the NF-E2p18 protein, could bind to NF-E2/AP-1 binding sites, and since NF-E2 binding sites seem to be required for globin gene expression during erythroid dierentiation, we hypothesised an inhibitory eect of c-jun expression on NF-E2 transcriptional activity in F-MEL cells. In this study, we have investigated and compared the eect of c-Jun and NF-E2p18 on AP-1 and NF-E2/AP-1 activities by performing transient transcription assays in Friend erythroid cells and in non-erythroid cells.
c-jun enhances and NF-E2p18 inhibits AP-1 activity in both erythroid and non-erythroid cells Since c-Jun and NF-E2p18, as homo-or heterodimers, are known to bind the AP-1 related sites (Kerppola and Curran, 1994), we ®rst evaluated their eect on AP-1 site transcriptional activity in F-MEL cells by using the classical 5xTRE-tk-CAT reporter vector (Figure 1 ). Transient transfection with this plasmid of F-MEL 745A cell line, in which c-jun transcripts are undetectable, resulted in a 4-fold induction of AP-1 activity, while transfection of F-MEL TFP10 cell line, expressing endogenous c-jun (Francastel et al., 1992 (Francastel et al., , 1994 , induced a 30-fold increase in AP-1 sitedependent transcription compared to the control plasmid tk-CAT ( Figure 2a ). The basal AP-1 activity was increased in both 745A and TFP10 cells by Figure 1 Description of the reporter expression used in this study. 5xTRE-tk-CAT contains ®ve AP-1 DNA-binding sites upstream of the thymidine kinase (tk) promoter driving expression of the chloramphenicol acetyl transferase (CAT) reporter gene. The construct 5xTRE-tk-CAT kindly provided by Dr E Ser¯ing (WuÈ rzburg, Germany) has been described elsewhere (Angel et al., 1987) . NFE2-SV-CAT contains the b-globin tandem NF-E2 sites, the SV40 promoter and the CAT reporter gene. To construct NFE2-SV-CAT, we synthesised single-strand oligonucleotides containing a 46-base-pair (bp) enhancer element including a tandem NF-E2/AP-1 motif according to Walters and Martin (1992) : (5'-ctagaTCAAGCACAGCAATGCTGAGTCATGATGAGTCATGCTGAGGCTTActgca-3') and (3'-tA-GTTCGTGTCGTTACGACTCAGTACTAC TCAGTACGACTCCGAATg-5'). They were annealed and cloned at the XbaI/PstI sites of the pSV-CAT reporter plasmid (Promega). The minimal erythroid promoter construct (GATA-NFE2-hGH) has been previously described elsewhere (Walters and Martin, 1992) Figure 2 Eects of c-Jun and NF-E2p18 on AP-1 transcriptional activity in both erythroid and non-erythroid cells (a) F-MEL cells and (b) NIH3T3 cells were transfected with 10 mg of the tk-CAT control plasmid lacking AP-1 sites, or 10 mg of the 5xTRE-tk-CAT plasmid. When indicated, 5xTRE-tk-CAT was cotransfected with 40 mg of plasmids expressing full-length c-jun (pSVc-junS) or NFE2p18 (pSVp18). CAT enzymatic activity (% of conversion) is indicated. Errors bars represent standard error of the mean. Methods: NIH3T3 and F-MEL cells, strain 745A and TFP10 (Robert-LeÂ zeÂ neÁ s et al., 1988) were grown in RPMI-1640 medium (Gibco) containing 10% fetal calf serum (FCS, Eurobio). For each transfection, log-phase cells were washed in phosphate-buered saline (PBS), pelleted and resuspended in ice cold PBS/HEPES 50 mM. Electroporations were performed using the Bio-Rad Gene Pulser with conditions of 400V and 500 mF for NIH3T3 cells, 370 V and 500 mF for F-MEL cells, 10 mg of supercoiled reporter construct (tk-CATor 5xTRE-tk-CAT) and 10 7 cells in 0.4 ml of PBS/50 mM HEPES/10 mg salmon sperm DNA. The tk-CAT construct, which lacks the AP-1 element, served as the control for AP-1 speci®c transcriptional activity. Transfection mixture also contained 40 mg of supercoiled expression vectors. The c-jun sense expression vector (pSVc-junS) has been described previously (Francastel et al., 1994) . NF-E2p18 (pSVp18) and NF-E2p45 (pSVp45) sense expression vectors were obtained by ligation of murine NF-E2p18 full length cDNA or NF-E2p45 full length cDNA (generous gifts from N Andrews, Boston) into EcoRI-digested pSVsport1 (BRL), under the control of the SP6 or the SV40 promoters. In vitro translated proteins were prepared using 1 mg of these expression vectors, SP6 polymerase and TNT-lysate-reticulocyte kit (Promega) to check the size of the proteins produced. 48 h after electroporation, cells were washed twice in PBS and lysed in Tris-HCl 250 mM/pH 8 by three cycles of freeze/thawing. After centrifugation to eliminate cell debris, extracts were heated at 608C to eliminate endogenous acetylases. The protein concentration of the supernatant was determined by the Bradford assay. CAT activity was assayed in 200 ml reactions containing 20 mg of total cell extracts, 0.2 mCi [( 14 C] chloramphenicol (NEN), 2 mM acetylcoenzyme A. After a 16 h incubation at 378C chloramphenicol and acetyled products were extracted by ethyl acetate. The acetylated products were separated from unacetylated chloramphenicol by thin-layer chromatography in chloroform/5% methanol. Quanti®cation of both unacetylated (U) and acetylated (A) forms of [( 14 C)] was performed using a Phosphorimager (Molecular Dynamics) and % of conversion calculated as follows: A*100/(U+A). For each experiment, three plasmid preparations were used. Data represent mean+standard error (SE) for three experiments c-Jun and NF-E2 activity in erythroleukemia cells C Francastel et al cotransfection with c-jun sense expression vector (pSVcjunS). In contrast, cotransfection of both F-MEL cell lines with the NF-E2p18 expression vector (pSVp18) alone, or pSVp18 together with pSVc-junS, resulted in a marked decrease in AP-1 activity (Figure 2a) . To compare the eect of c-Jun and NF-E2p18 proteins on AP-1 activity in non-erythroid cells, NIH3T3 cells, used as control cells, were also transiently transfected with the 5xTRE-tk-CAT vector. As expected, we detected signi®cant endogenous AP-1 activity which was slightly increased by c-jun overexpression ( Figure 2b ). As observed in F-MEL cells, a marked decrease in AP-1 activity was obtained in NIH3T3 cells by cotransfection with NF-E2p18 alone or NF-E2p18 together with pSVc-junS (Figure 2b ).
c-jun activates and NF-E2p18 inhibits NF-E2/AP-1 activity in non-erythroid cells
We next analysed NF-E2/AP-1 dependent reporter gene expression by performing transient transfection experiments in the presence of c-jun or NF-E2p18 expression vectors. For this analysis, an oligonucleotide carrying the human b-globin enhancer tandem NF-E2 sites was inserted into a SV-CAT expression vector to generate SV-NFE2-CAT (Figure 1) . Transfection of non-erythroid NIH3T3 cells with SV-NFE2-CAT resulted in an increase in CAT activity compared to transfection of cells with a control of SV-CAT plasmid containing only the SV40 promoter (Figure 3a) . These results are not surprising since the NF-E2 site encompasses a perfect AP-1 site. Moreover, NF-E2 activity in NIH3T3 was increased by c-jun expression and dramatically reduced by NF-E2p18 expression (Figure 3a) , the latter observation being in agreement with the work of Igarashi et al. (1994) . This inhibitory eect of NF-E2p18 on NF-E2 activity was also obtained in NIH3T3 cells by cotransfection with pSVp18 together with pSVc-junS (Figure 3a) . These results suggest that in non-erythroid cells, c-Jun and NF-E2p18 regulate the NF-E2/AP-1 site in the same way as an AP-1 site (compare Figures 2b and 3a) . GATA-NFE2-hGH was cotransfected with 40 mg of plasmids expressing full-length c-jun (pSVc-junS), NF-E2p18 (pSVp18) or c-jun antisense transcripts (pSVc-junAS). Forty-eight h after electroporation, medium was harvested and 10 ml was assayed for hGH using an ELISA kit (Eurogenetics) according to the manufacturer recommendations. hGH levels in culture medium are indicated. The results consist of average of three separate experiments and error bars represent standard error (SE) of the mean c-Jun and NF-E2 activity in erythroleukemia cells C Francastel et al c-jun or NF-E2p18 activates NF-E2/AP-1 activity in erythroid cells but their association is inactive As seen on Figure 3b , endogenous NF-E2 site dependent activity is very weak in F-MEL cells, while it is a little stronger in c-jun expressing TFP-10 cells. These results are in agreement with the work of Walters and Martin (1992) in which they have shown that NF-E2 sites are strong positive regulators of erythroid gene expression, but only when linked to other cis-acting elements from the human b-globin locus. However, the NF-E2 element responded to c-jun overexpression, and its activity was increased by about sixfold in 745A cells and in TFP10 cells (Figure 3b) . Cotransfection with pSVp18 also led to an increase in NF-E2 activity in 745A cells (threefold) and in TFP10 cells (®vefold), whereas cotransfection with pSVp45 had no eect on NF-E2 activity in F-MEL cells. While NF-E2p18 transfected alone or together with pSVp45 activate NF-E2 driven gene expression in F-MEL cells, cotransfection with c-jun together with NF-E2p18 had no eect on NF-E2/AP-1 activity in 745A cells and decreased this activity in TFP10 cells (Figure 3b) .
In order to con®rm the results obtained on NF-E2 sites linked to the SV40 heterologous promoter, we have studied the eect of c-jun and p18 expression vectors on the minimal erythroid promoter described by Walters and Martin (1992) . This minimal promoter (GATA-NF-E2-hGH) contains a globin TATA box under the control of the b-globin tandem NF-E2 sites and a binding site for one other erythroid transcriptional factor GATA-1 (see Figure 1) . As in the case of experiments using the SV-NFE2-CAT plasmid, although c-jun or NF-E2p18 overexpression resulted in two-or threefold increase in hGH reporter gene expression, cotransfection with both pSVc-junS and pSVp18 together did not increase transcription from this minimal erythroid promoter in F-MEL cells (Figure 3c ).
Antisense c-jun decreases AP-1 activity but increases NF-E2/AP-1 activity in erythroid cells
Since c-Jun could activate NF-E2 activity when present alone but not when associated with NF-E2p18 (Figure  3) , is was interesting to analyse the eect of the inhibition of endogenous c-jun expression by antisense c-jun transcripts on the activity of NF-E2 sites in both erythroid and non-erythroid cell lines. Inhibition of cjun expression by transfection with c-jun antisense expression vector (pSVc-junAS) led to a dramatic inhibition of both AP-1 and NF-E2/AP-1 activity in non-erythroid NIH3T3 cells (Figure 4a and b) . In contrast, transfection with pSVc-junAS decreased endogenous AP-1 activity but led to an increase in endogenous NF-E2 activity in F-MEL cells (Figure 4c When indicated, NFE2-SV-CAT was cotransfected with 40 mg of plasmids expressing c-jun (pSVc-junAS), junB (pSVjunBAS) or junD (pSVjunDAS) antisense transcripts. The antisense expression vectors pSVc-junAS, pSVjunBAS and pSVjunDAS have been described previously (Francastel et al., 1994) . CAT enzymatic activity (% of conversion) is indicated. Results represent the average (+SE) of three independent experiments c-Jun and NF-E2 activity in erythroleukemia cells C Francastel et al and d). These results clearly show that in erythroid cells the activity of AP-1 and NF-E2/AP-1 sites can be distinguished by the inhibition of endogenous c-jun using antisense expression vectors, whereas they are indistinguishable in non-erythroid cells. The eect of antisense transcripts is more dramatic in TFP10 c-jun expressing cells in which we obtained a 30-fold increase in NF-E2 activity, whereas only a fourfold increase in NF-E2 activity was observed in 745A cells. Antisense junB or antisense junD expression vectors had little or no eect on NF-E2 driven reporter gene expression in F-MEL cells (Figure 4d ). These results suggest that endogenous c-Jun, but not JunB nor JunD, may act as a negative regulator of NF-E2/AP-1 transcriptional activity in erythroid F-MEL cells. Moreover, we found that the inhibition of endogenous c-jun expression in F-MEL cells by cotansfection with pSVc-junAS also increased the activity of the miminal erythroid promoter containing NF-E2/AP-1 and GATA sites (see Figure 3c ). In summary, we report that although c-Jun acts as a positive regulator of NF-E2/AP-1 activity, cotransfection of c-Jun together with NF-E2p18 is not able to increase this activity in erythroid F-MEL cells. These results suggest that c-Jun can indeed act as a negative regulator of NF-E2 transcriptional activity, when associated with NF-E2p18 protein. Since it was reported that Maf/Jun heterodimers can bind NF-E2/ AP-1 like sites more eciently than c-Jun homodimers or Maf homodimers Kerppola and Curran, 1994) , NF-E2 activity may be repressed by formation of c-Jun/NF-E2p18 heterodimers that are unable to activate transcription from these sites. Similarly, recent studies have shown that c-Fos can act as a negative regulator of transcription in combination with the small Maf proteins (Kataoka et al., 1995) . Although we favor the model of inactive cJun/p18 complexes, two alternative explanations of our results may be considered. The ®rst is that transcriptional activation from NF-E2 sites in F-MEL cells can be dysregulated by sequestration of NF-E2p18 by cJun, resulting in a decrease in the amount of the NFE2p45/p18 complex which is the functional form of the NF-E2 transcription factor. A second explanation could be that c-Jun directly occludes the transactivation domain of the NF-E2 p45/p18 complex. Finally, since NF-E2 sites seem to be required for globin gene expression, this interaction between c-Jun and NF-E2 may provide a mechanism by which the protooncogene c-Jun, one of the major components of the ubiquitous transcription factor AP-1, can block the dierentiation of Friend erythroleukemia cells.
